Events Search and Views Navigation

Event Views Navigation

Today

Sickle Cell Disease: The State of Patients & Progress in Ohio

The Ohio Statehouse 1 Capitol Square, Columbus

In the United States, the CDC estimates that 100,000 Americans have sickle cell disease (SCD). About 90% of people with SCD are of African descent. SCD also occurs in Hispanic, South Asian, Middle Eastern, and Southern European ancestry. A panel of experts, moderated by BioOhio's Eddie Pauline, will discuss current programs that assist patients and families, as well as how Ohio’s hospital and health systems are contributing to SCD research and advancements in treatment.

Founders Unfiltered: A Conversation with Dr. Dan German, Founder of Orthobrain

Online Event

Join JumpStart on Wednesday, March 23, for the next Founders Unfiltered featuring Dr. Dan German, founder of orthobrain. An award-winning orthodontist, Dr. German is well known throughout the dental world. Now he’s helping dentists seamlessly integrate orthodontics into their practice by providing education and real-time support through orthobrain’s innovative platform. Tune in to find out how Dr. German set out to resolve the unmet demand for orthodontics and hear more about how he went from dental practitioner to tech founder.

Virtual Medtech Happy Hour: Securing Non-Dilutive Funding Through SBIR/STTR Grants

Online Event

This event is presented by Project Medtech. Grab your favorite drink (or just a drink), come learn and interact with industry experts while they discuss hot topics in Medtech. Dr. Ashley Mooneyham is President and Director of Grants at Superior Medical Experts, a medical writing and research support company. As Director of Grants, she has helped small businesses in the healthcare innovation space secure over $14 million in non-dilutive seed funding through the SBIR/STTR grant program. Superior Medical Experts provides comprehensive grant assistance that spans company registrations, grant strategy consulting, full research and compliance drafting, and submission in as little as 12 weeks.

Clinical Challenges Under the EU MDR

Online Event

With the EU Medical Device Regulation (MDR) now fully applicable, manufacturers are facing the challenges of both transitioning legacy devices to the MDR, and introducing new products. Although the Medical Device Coordination Group (MDCG) guidance has been forthcoming, there remain significant gaps in guidance and interpretation of requirements, and varying interpretations of expectations. In addition with the limited number of Notified Bodies designated under the MDR, there is substantial pressure to make MDR submissions as soon as possible to avoid the “cliff edge” of May 2024. NAMSA invites you to join this upcoming webinar as our team of regulatory experts discuss practical insights to address these challenges.

Humanizing Healthcare: Elevating Health Experiences

Online Event

The surge in digital healthcare technologies has reshaped the healthcare experience for consumers. Consumers are looking for more personalized health experiences where they are in control of their health but they are also more aware of the risks and benefits of sharing their data. Now more than ever, it’s important organizations understand how to use technology to deliver value while addressing consumer concerns around data, consent and security.

The Need for Transitional Coverage for Emerging Technologies (TCET)

Online Event

For patients on Medicare, the majority of whom are over age 65, time matters. However, newly published research from the Stanford Byers Center for Biodesign shows that patients can wait up to 5 years after FDA authorization to access new medical technologies. Instead, a well-designed transitional coverage program could greatly accelerate patients’ access to care, while reducing the overall cost burden on our healthcare system. This program would also encourage innovation in areas of critically important unmet clinical needs. The Duke-Margolis Center for Health Policy has recommended the addition of several key elements to a transitional coverage pathway, highlighting the need for early engagement between stakeholders to inform and guide evidence development and appropriate use of novel technologies. Please join us to explore these findings and hear the perspectives of physicians, innovators and CMS stakeholders on this important initiative to advance patient care.

The Conference on Innovations in Climate Resilience

Columbus, OH

The Conference on Innovations in Climate Resilience, presented by Battelle in collaboration with DOE National Laboratories, offers a curated technical program with invited keynote presentations, platform and lightning talks and a poster reception. We’re expecting an audience of government leaders, entrepreneurs and innovators to explore breakthroughs in technology, science, policy and infrastructure that will help mitigate the threats to our environment, health, communities, national security and economic well-being from a changing climate.

2022 Engineering Graduate Student & Postdoc Industry Recruitment Event

Online Event

The Ohio State University and the College of Engineering would like to invite you and your colleagues to join us for the VIRTUAL 2022 Graduate Student & Postdoc Industry Recruitment Event on Tuesday, April 5th! If you are looking to fill internships or entry-level positions with diverse, high-caliber engineers at the M.S., Ph.D., or Postdoctoral levels, then this is the event for you. Come join us!

2022 Engineering Spring Into Your Career Fair

The Ohio State University Columbus

The Engineering Society of Professional Excellence (ESPE) in partnership with Engineering Career Services will host the Spring Into Your Career Fair (IN PERSON) on Wednesday, April 6th 2:00 p.m. – 5:00 p.m. at the Performance Hall in the Ohio Union. The Spring Into Your Career is an excellent opportunity to fill immediate needs within your organization with interested, highly qualified Ohio State engineering and computer science students seeking co-op, internship, and career employment opportunities for summer and fall 2022.

Transitioning from EUA to 510(k) for IVD Products: Planning to Execution

Online Event

In 2020, NAMSA hosted, “Transitioning from EUA to 510(k) Clearance for IVD Products: What to Expect?,” which focused on necessary regulatory, clinical and quality steps required to move from EUA to 510(k) approval. Two years later, we all have a stronger understanding of the expiration timeline for the Emergency Use Authorization (EUA) and a clearer picture of how to prepare for the upcoming changes. NAMSA invites you to attend this webinar where we will unpack the U.S. FDA draft guidance and discuss best practices for identifying gaps and maximizing your on-market product for a successful 510(k) submission, including an execution plan to achieve a quick and timely 510(k) approval.